BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antonioli L, Blandizzi C, Pacher P, Haskó G. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases. Pharmacol Rev 2019;71:345-82. [PMID: 31235653 DOI: 10.1124/pr.117.014878] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Magni G, Ceruti S. Adenosine Signaling in Autoimmune Disorders. Pharmaceuticals (Basel) 2020;13:E260. [PMID: 32971792 DOI: 10.3390/ph13090260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 de Sire A, Marotta N, Ferrillo M, Agostini F, Sconza C, Lippi L, Respizzi S, Giudice A, Invernizzi M, Ammendolia A. Oxygen-Ozone Therapy for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review. Int J Mol Sci 2022;23:2528. [PMID: 35269681 DOI: 10.3390/ijms23052528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yu F, Zhu C, Xie Q, Wang Y. Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. J Med Chem 2020;63:12196-212. [PMID: 32667814 DOI: 10.1021/acs.jmedchem.0c00237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nation CS, Da'dara AA, Elzoheiry M, Skelly PJ. Schistosomes Impede ATP-Induced T Cell Apoptosis In Vitro: The Role of Ectoenzyme SmNPP5. Pathogens 2022;11:155. [DOI: 10.3390/pathogens11020155] [Reference Citation Analysis]
5 Lammers MD, Anéli NM, de Oliveira GG, de Oliveira Maciel SF, Zanini D, Mânica A, de Resende e Silva DT, Bagatini MD, Sévigny J, De Sá CA, Manfredi LH, Cardoso AM. The anti-inflammatory effect of resistance training in hypertensive women: the role of purinergic signaling. Journal of Hypertension 2020;38:2490-500. [DOI: 10.1097/hjh.0000000000002578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yegutkin GG. Adenosine metabolism in the vascular system. Biochem Pharmacol 2021;187:114373. [PMID: 33340515 DOI: 10.1016/j.bcp.2020.114373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pietrowski MJ, Gabr AA, Kozlov S, Blum D, Halle A, Carvalho K. Glial Purinergic Signaling in Neurodegeneration. Front Neurol 2021;12:654850. [PMID: 34054698 DOI: 10.3389/fneur.2021.654850] [Reference Citation Analysis]
8 Salmaso V, Jacobson KA. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design. ChemMedChem 2020;15:1958-73. [PMID: 32803849 DOI: 10.1002/cmdc.202000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Wang X, Liu D, Qin W, Liu Y, Yuan X, Zhang X, Dai C, Zhang D. P2RX1-Involved Glycolytic Metabolism Supports Neutrophil Activation in Acute Pancreatitis. Front Immunol 2020;11:549179. [PMID: 33603729 DOI: 10.3389/fimmu.2020.549179] [Reference Citation Analysis]
10 Guieu R, Brignole M, Deharo JC, Deharo P, Mottola G, Groppelli A, Paganelli F, Ruf J. Adenosine Receptor Reserve and Long-Term Potentiation: Unconventional Adaptive Mechanisms in Cardiovascular Diseases? Int J Mol Sci 2021;22:7584. [PMID: 34299203 DOI: 10.3390/ijms22147584] [Reference Citation Analysis]
11 Reichert KP, Castro MFV, Assmann CE, Bottari NB, Miron VV, Cardoso A, Stefanello N, Morsch VMM, Schetinger MRC. Diabetes and hypertension: Pivotal involvement of purinergic signaling. Biomed Pharmacother 2021;137:111273. [PMID: 33524787 DOI: 10.1016/j.biopha.2021.111273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Thude H, Onken L, Kappauf J, Dworak M, Sterneck M, Peine S, Nashan B, Koch M. Ectonucleoside triphosphate diphosphohydrolase 1 and 5'-nucleotidase ecto gene polymorphisms and acute cellular rejection after liver transplantation. HLA 2020;96:64-9. [PMID: 32248630 DOI: 10.1111/tan.13892] [Reference Citation Analysis]
13 Yin HY, Fan YP, Liu J, Li DT, Guo J, Yu SG. Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model. Purinergic Signal 2021. [PMID: 34378078 DOI: 10.1007/s11302-021-09815-5] [Reference Citation Analysis]
14 Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM. Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 2021;476:2891-8. [PMID: 33740184 DOI: 10.1007/s11010-021-04130-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 El-Naccache DW, Haskó G, Gause WC. Early Events Triggering the Initiation of a Type 2 Immune Response. Trends Immunol 2021;42:151-64. [PMID: 33386241 DOI: 10.1016/j.it.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Antonioli L, Pacher P, Haskó G. Adenosine and inflammation: it's time to (re)solve the problem. Trends Pharmacol Sci 2021:S0165-6147(21)00199-1. [PMID: 34776241 DOI: 10.1016/j.tips.2021.10.010] [Reference Citation Analysis]
17 Ferrari D, Casciano F, Secchiero P, Reali E. Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis. Int J Mol Sci 2021;22:9449. [PMID: 34502368 DOI: 10.3390/ijms22179449] [Reference Citation Analysis]
18 Berekméri E, Fekete Á, Köles L, Zelles T. Postnatal Development of the Subcellular Structures and Purinergic Signaling of Deiters' Cells along the Tonotopic Axis of the Cochlea. Cells 2019;8:E1266. [PMID: 31627326 DOI: 10.3390/cells8101266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Abruzzese V, Sukowati CHC, Tiribelli C, Matera I, Ostuni A, Bisaccia F. The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways. Pathophysiology 2022;29:173-86. [DOI: 10.3390/pathophysiology29020015] [Reference Citation Analysis]
20 Li Y, Lou Y, Chen Y, Yang J, Li D, Jiang B, Lan J, Wen J, Fu Y, Zhang Y, Tao J, Zhu J. Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases. Theranostics 2021;11:3694-709. [PMID: 33664856 DOI: 10.7150/thno.52891] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sun L, Ouyang J, Zeng Z, Zeng C, Ma Y, Zeng F, Wu S. Targeted and activatable nanosystem for fluorescent and optoacoustic imaging of immune-mediated inflammatory diseases and therapy via inhibiting NF-κB/NLRP3 pathways. Bioact Mater 2022;10:79-92. [PMID: 34901531 DOI: 10.1016/j.bioactmat.2021.08.010] [Reference Citation Analysis]
22 Coppi E, Dettori I, Cherchi F, Bulli I, Venturini M, Lana D, Giovannini MG, Pedata F, Pugliese AM. A2B Adenosine Receptors: When Outsiders May Become an Attractive Target to Treat Brain Ischemia or Demyelination. Int J Mol Sci 2020;21:E9697. [PMID: 33353217 DOI: 10.3390/ijms21249697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
23 Di Virgilio F, Sarti AC, Coutinho-Silva R. Purinergic signaling, DAMPs, and inflammation. Am J Physiol Cell Physiol 2020;318:C832-5. [PMID: 32159362 DOI: 10.1152/ajpcell.00053.2020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
24 Ye J. Mechanism of insulin resistance in obesity: a role of ATP. Front Med 2021;15:372-82. [PMID: 34047935 DOI: 10.1007/s11684-021-0862-5] [Reference Citation Analysis]
25 Antonioli L, Lucarini E, Lambertucci C, Fornai M, Pellegrini C, Benvenuti L, Di Cesare Mannelli L, Spinaci A, Marucci G, Blandizzi C, Ghelardini C, Volpini R, Dal Ben D. The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis. Cells 2020;9:E1509. [PMID: 32575844 DOI: 10.3390/cells9061509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Haas CB, Lovászi M, Pacher P, de Souza PO, Pelletier J, Leite RO, Sévigny J, Németh Z, Braganhol E, Haskó G. Extracellular ectonucleotidases are differentially regulated in murine tissues and human polymorphonuclear leukocytes during sepsis and inflammation. Purinergic Signal 2021. [PMID: 34604944 DOI: 10.1007/s11302-021-09819-1] [Reference Citation Analysis]
27 Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and Inflammation: Here, There and Everywhere. Int J Mol Sci 2021;22:7685. [PMID: 34299305 DOI: 10.3390/ijms22147685] [Reference Citation Analysis]
28 Kim B, Guaregua V, Chen X, Zhao C, Yeow W, Berg NK, Eltzschig HK, Yuan X. Characterization of a Murine Model System to Study MicroRNA-147 During Inflammatory Organ Injury. Inflammation 2021;44:1426-40. [PMID: 33566257 DOI: 10.1007/s10753-021-01427-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Eberhardt N, Bergero G, Mazzocco Mariotta YL, Aoki MP. Purinergic modulation of the immune response to infections. Purinergic Signal 2022. [PMID: 34997903 DOI: 10.1007/s11302-021-09838-y] [Reference Citation Analysis]
30 Dal Ben D, Antonioli L, Lambertucci C, Spinaci A, Fornai M, D'Antongiovanni V, Pellegrini C, Blandizzi C, Volpini R. Approaches for designing and discovering purinergic drugs for gastrointestinal diseases. Expert Opin Drug Discov 2020;15:687-703. [PMID: 32228110 DOI: 10.1080/17460441.2020.1743673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Sluyter R, Watson D. Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity. Front Pharmacol 2020;11:596357. [PMID: 33123018 DOI: 10.3389/fphar.2020.596357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lopez V, Schäkel L, Schuh HJM, Schmidt MS, Mirza S, Renn C, Pelletier J, Lee SY, Sévigny J, Alban S, Bendas G, Müller CE. Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39. Mar Drugs 2021;19:51. [PMID: 33499103 DOI: 10.3390/md19020051] [Reference Citation Analysis]
33 D'Antongiovanni V, Fornai M, Pellegrini C, Benvenuti L, Blandizzi C, Antonioli L. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. Int J Mol Sci 2020;21:E5089. [PMID: 32708507 DOI: 10.3390/ijms21145089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Bragança B, Correia-de-Sá P. Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases. Int J Mol Sci 2020;21:E5005. [PMID: 32679900 DOI: 10.3390/ijms21145005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Antonioli L, Fornai M, Pellegrini C, Bertani L, Nemeth ZH, Blandizzi C. Inflammatory Bowel Diseases: It's Time for the Adenosine System. Front Immunol 2020;11:1310. [PMID: 32849492 DOI: 10.3389/fimmu.2020.01310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Enders M, Heider T, Ludwig A, Kuerten S. Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium. Int J Mol Sci 2020;21:E1663. [PMID: 32121306 DOI: 10.3390/ijms21051663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
37 Hlapčić I, Hulina-Tomašković A, Somborac-Bačura A, Rajković MG, Dugac AV, Popović-Grle S, Rumora L. Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease. Sci Rep 2019;9:15349. [PMID: 31653924 DOI: 10.1038/s41598-019-51855-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Falcone C, Caracciolo M, Correale P, Macheda S, Vadalà EG, La Scala S, Tescione M, Danieli R, Ferrarelli A, Tarsitano MG, Romano L, De Lorenzo A. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome? J Clin Med 2020;9:E3045. [PMID: 32967358 DOI: 10.3390/jcm9093045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 Díaz-Muñoz M, Hernández-Muñoz R, Butanda-Ochoa A. Structure-activity features of purines and their receptors: implications in cell physiopathology. Mol Biomed 2022;3:5. [PMID: 35079944 DOI: 10.1186/s43556-022-00068-1] [Reference Citation Analysis]
40 Antonioli L, Haskó G. May be adenosine an immuno-quorum-sensing signal? Purinergic Signalling. [DOI: 10.1007/s11302-022-09866-2] [Reference Citation Analysis]
41 Cao X, Ye X, Zhang S, Wang L, Xu Y, Peng S, Zhou Y, Peng Y, Li J, Zhang X, Han X, Huang WY, Jia W, Ye J. ADP Induces Blood Glucose Through Direct and Indirect Mechanisms in Promotion of Hepatic Gluconeogenesis by Elevation of NADH. Front Endocrinol (Lausanne) 2021;12:663530. [PMID: 33986729 DOI: 10.3389/fendo.2021.663530] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Wirsching E, Fauler M, Fois G, Frick M. P2 Purinergic Signaling in the Distal Lung in Health and Disease. Int J Mol Sci 2020;21:E4973. [PMID: 32674494 DOI: 10.3390/ijms21144973] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
43 Ledderose C, Valsami E, Junger WG. Optimized HPLC method to elucidate the complex purinergic signaling dynamics that regulate ATP, ADP, AMP, and adenosine levels in human blood. Purinergic Signalling. [DOI: 10.1007/s11302-022-09842-w] [Reference Citation Analysis]
44 Kong Q, Quan Y, Tian G, Zhou J, Liu X. Purinergic P2 Receptors: Novel Mediators of Mechanotransduction. Front Pharmacol 2021;12:671809. [PMID: 34025431 DOI: 10.3389/fphar.2021.671809] [Reference Citation Analysis]
45 Coppi E, Cencetti F, Cherchi F, Venturini M, Donati C, Bruni P, Pedata F, Pugliese AM. A2 B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis. Front Neurosci 2021;15:677988. [PMID: 34135730 DOI: 10.3389/fnins.2021.677988] [Reference Citation Analysis]
46 Ledderose C, Bromberger S, Slubowski CJ, Sueyoshi K, Junger WG. Frontline Science: P2Y11 receptors support T cell activation by directing mitochondrial trafficking to the immune synapse. J Leukoc Biol 2021;109:497-508. [PMID: 32531829 DOI: 10.1002/JLB.2HI0520-191R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Romero-Martínez BS, Montaño LM, Solís-Chagoyán H, Sommer B, Ramírez-Salinas GL, Pérez-Figueroa GE, Flores-Soto E. Possible Beneficial Actions of Caffeine in SARS-CoV-2. Int J Mol Sci 2021;22:5460. [PMID: 34067243 DOI: 10.3390/ijms22115460] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation. Front Immunol 2020;11:1205. [PMID: 32655557 DOI: 10.3389/fimmu.2020.01205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Leão Batista Simões J, Fornari Basso H, Cristine Kosvoski G, Gavioli J, Marafon F, Elias Assmann C, Barbosa Carvalho F, Dulce Bagatini M. Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue. Int Immunopharmacol 2021;100:108150. [PMID: 34537482 DOI: 10.1016/j.intimp.2021.108150] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Baqi Y, Rashed M, Schäkel L, Malik EM, Pelletier J, Sévigny J, Fiene A, Müller CE. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3. Front Pharmacol 2020;11:1282. [PMID: 32973513 DOI: 10.3389/fphar.2020.01282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Li X, Berg NK, Mills T, Zhang K, Eltzschig HK, Yuan X. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury. Front Immunol 2020;11:604944. [PMID: 33519814 DOI: 10.3389/fimmu.2020.604944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Baldissera MD, Souza CF, Tavares GC, Valladão GMR, Da Silva AS, Antoniazzi A, Cunha MA, Baldisserotto B. Purinergic signaling and gene expression of purinoceptors in the head kidney of the silver catfish Rhamdia quelen experimentally infected by Flavobacterium columnare. Microb Pathog 2020;142:104070. [PMID: 32081613 DOI: 10.1016/j.micpath.2020.104070] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Francucci B, Dal Ben D, Lambertucci C, Spinaci A, Volpini R, Marucci G, Buccioni M. A patent review of adenosine A2B receptor antagonists (2016-present). Expert Opin Ther Pat 2022;:1-24. [PMID: 35387537 DOI: 10.1080/13543776.2022.2057222] [Reference Citation Analysis]
54 Ciruela F, Jacobson KA. Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis? Front Immunol 2022;13:904762. [DOI: 10.3389/fimmu.2022.904762] [Reference Citation Analysis]
55 Eggers M, Rühl F, Haag F, Koch-Nolte F. Nanobodies as probes to investigate purinergic signaling. Biochem Pharmacol 2021;187:114394. [PMID: 33388283 DOI: 10.1016/j.bcp.2020.114394] [Reference Citation Analysis]
56 Bhagavatham SKS, Khanchandani P, Kannan V, Potikuri D, Sridharan D, Pulukool SK, Naik AA, Dandamudi RB, Divi SM, Pargaonkar A, Ray R, Santha SSR, Seshagiri PB, Narasimhan K, Gumdal N, Sivaramakrishnan V. Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis. Sci Rep 2021;11:15129. [PMID: 34301999 DOI: 10.1038/s41598-021-94607-5] [Reference Citation Analysis]
57 Sharma D, Farrar JD. Adrenergic regulation of immune cell function and inflammation. Semin Immunopathol 2020;42:709-17. [PMID: 33219396 DOI: 10.1007/s00281-020-00829-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
58 Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. Int J Mol Sci 2021;22:7952. [PMID: 34360719 DOI: 10.3390/ijms22157952] [Reference Citation Analysis]
59 Larrañaga-Vera A, Marco-Bonilla M, Largo R, Herrero-Beaumont G, Mediero A, Cronstein B. ATP transporters in the joints. Purinergic Signal 2021. [PMID: 34392490 DOI: 10.1007/s11302-021-09810-w] [Reference Citation Analysis]
60 Coppi E, Cherchi F, Fusco I, Dettori I, Gaviano L, Magni G, Catarzi D, Colotta V, Varano F, Rossi F, Bernacchioni C, Donati C, Bruni P, Pedata F, Cencetti F, Pugliese AM. Adenosine A2B receptors inhibit K+ currents and cell differentiation in cultured oligodendrocyte precursor cells and modulate sphingosine-1-phosphate signaling pathway. Biochem Pharmacol 2020;177:113956. [PMID: 32251679 DOI: 10.1016/j.bcp.2020.113956] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
61 Feng J, Armillei MK, Yu AS, Liang BT, Runnels LW, Yue L. Ca2+ Signaling in Cardiac Fibroblasts and Fibrosis-Associated Heart Diseases. J Cardiovasc Dev Dis 2019;6:E34. [PMID: 31547577 DOI: 10.3390/jcdd6040034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
62 Szopa A, Socała K, Serefko A, Doboszewska U, Wróbel A, Poleszak E, Wlaź P. Purinergic transmission in depressive disorders. Pharmacol Ther 2021;224:107821. [PMID: 33607148 DOI: 10.1016/j.pharmthera.2021.107821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Lopez V, Lee SY, Stephan H, Müller CE. Recombinant expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors. Anal Biochem 2020;603:113774. [PMID: 32445636 DOI: 10.1016/j.ab.2020.113774] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
64 Haas CB, Lovászi M, Braganhol E, Pacher P, Haskó G. Ectonucleotidases in Inflammation, Immunity, and Cancer. J Immunol 2021;206:1983-90. [PMID: 33879578 DOI: 10.4049/jimmunol.2001342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]